CTX stem cells(Reneuron)

N/A

Report date: 2022/12/31 20:28:42

Base Information

Drug NameCTX stem cells(Reneuron)
Drug Alias NameCTX 0E03 neural stem cells(Reneuron)ReN-001(Reneuron)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeHemiplegiaParalysis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesReneuron Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Fosun Pharmaceutical (Group) Co LtdReneuron Ltd
Inactive CompaniesThe University Of Texas MD Anderson Cancer Center
Active IndicationsStroke
Inactive IndicationsIschemic StrokeHemiplegiaParalysis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A